| Azithromycin for prevention of exacerbations of COPD RK Albert, J Connett, WC Bailey, R Casaburi, JAD Cooper Jr, GJ Criner, ... New England Journal of Medicine 365 (8), 689-698, 2011 | 1592 | 2011 |
| Chronic obstructive pulmonary disease phenotypes: the future of COPD MLK Han, A Agusti, PM Calverley, BR Celli, G Criner, JL Curtis, LM Fabbri, ... American journal of respiratory and critical care medicine 182 (5), 598-604, 2010 | 1559 | 2010 |
| Once-daily single-inhaler triple versus dual therapy in patients with COPD DA Lipson, F Barnhart, N Brealey, J Brooks, GJ Criner, NC Day, ... New England Journal of Medicine 378 (18), 1671-1680, 2018 | 1250 | 2018 |
| Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary A Agustí, BR Celli, GJ Criner, D Halpin, A Anzueto, P Barnes, J Bourbeau, ... European Respiratory Journal 61 (4), 2023 | 1190 | 2023 |
| Analysis of the lung microbiome in the “healthy” smoker and in COPD JR Erb-Downward, DL Thompson, MK Han, CM Freeman, L McCloskey, ... PloS one 6 (2), e16384, 2011 | 1135 | 2011 |
| Computed tomography–based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression CJ Galbán, MK Han, JL Boes, KA Chughtai, CR Meyer, TD Johnson, ... Nature medicine 18 (11), 1711-1715, 2012 | 830 | 2012 |
| Clinical significance of symptoms in smokers with preserved pulmonary function PG Woodruff, RG Barr, E Bleecker, SA Christenson, D Couper, JL Curtis, ... New England Journal of Medicine 374 (19), 1811-1821, 2016 | 753 | 2016 |
| Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study I Noth, Y Zhang, SF Ma, C Flores, M Barber, Y Huang, SM Broderick, ... The Lancet respiratory medicine 1 (4), 309-317, 2013 | 635 | 2013 |
| Pulmonary arterial enlargement and acute exacerbations of COPD JM Wells, GR Washko, MLK Han, N Abbas, H Nath, AJ Mamary, E Regan, ... New England journal of medicine 367 (10), 913-921, 2012 | 577 | 2012 |
| Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes MLK Han, EA Kazerooni, DA Lynch, LX Liu, S Murray, JL Curtis, GJ Criner, ... Radiology 261 (1), 274-282, 2011 | 523 | 2011 |
| Gender and chronic obstructive pulmonary disease: why it matters MLK Han, D Postma, DM Mannino, ND Giardino, S Buist, JL Curtis, ... American journal of respiratory and critical care medicine 176 (12), 1179-1184, 2007 | 512 | 2007 |
| Clinical and radiologic disease in smokers with normal spirometry EA Regan, DA Lynch, D Curran-Everett, JL Curtis, JHM Austin, ... JAMA internal medicine 175 (9), 1539-1549, 2015 | 482 | 2015 |
| The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study V Kim, MLK Han, GB Vance, BJ Make, JD Newell, JE Hokanson, ... Chest 140 (3), 626-633, 2011 | 418 | 2011 |
| Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study MLK Han, Y Zhou, S Murray, N Tayob, I Noth, VN Lama, BB Moore, ... The Lancet Respiratory Medicine 2 (7), 548-556, 2014 | 408 | 2014 |
| Simvastatin for the prevention of exacerbations in moderate-to-severe COPD GJ Criner, JE Connett, SD Aaron, RK Albert, WC Bailey, R Casaburi, ... New England Journal of Medicine 370 (23), 2201-2210, 2014 | 400 | 2014 |
| Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease SP Bhatt, X Soler, X Wang, S Murray, AR Anzueto, TH Beaty, AM Boriek, ... American journal of respiratory and critical care medicine 194 (2), 178-184, 2016 | 383 | 2016 |
| Airway mucin concentration as a marker of chronic bronchitis M Kesimer, AA Ford, A Ceppe, G Radicioni, R Cao, CW Davis, ... New England Journal of Medicine 377 (10), 911-922, 2017 | 374 | 2017 |
| GOLD 2011 disease severity classification in COPDGene: a prospective cohort study MLK Han, H Muellerova, D Curran-Everett, MT Dransfield, GR Washko, ... The lancet Respiratory medicine 1 (1), 43-50, 2013 | 350 | 2013 |
| Definition and nomenclature of chronic obstructive pulmonary disease: time for its revision B Celli, L Fabbri, G Criner, FJ Martinez, D Mannino, C Vogelmeier, ... American journal of respiratory and critical care medicine 206 (11), 1317-1325, 2022 | 345 | 2022 |
| Goals of COPD treatment: focus on symptoms and exacerbations CF Vogelmeier, M Roman-Rodriguez, D Singh, MLK Han, ... Respiratory medicine 166, 105938, 2020 | 331 | 2020 |
